Differentiated thyroid cancer: Impact of adjuvant external radiotherapy in patients with perithyroidal tumor infiltration (stage pT4)

Cancer

Volumn 77, Issue 1, 1996, Pages 172-180

  Farahati, Jamshid ^a,b   Reiners, Christoph ^a   Stuschke, Martin ^a   Müller, Stefan P ^a   Stüben, Georg ^a   Sauerwein, Wolfgang ^a   Sack, Horst ^a  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

^b UNIVERSITY HOSPITAL WÜRZBURG   (Germany)

Author keywords

external radiation; lymph node involvement; prognosis; thyroid cancer; tumor biology

Indexed keywords

LEVOTHYROXINE; RADIOACTIVE IODINE;

ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; FEMALE; HEAD AND NECK CANCER; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; THYROID CANCER; THYROIDECTOMY; TREATMENT OUTCOME;

ADENOCARCINOMA, FOLLICULAR; ADULT; AGE FACTORS; AGED; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; IODINE RADIOISOTOPES; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM RECURRENCE, LOCAL; OUTCOME ASSESSMENT (HEALTH CARE); PROGNOSIS; RADIOTHERAPY, ADJUVANT; RETROSPECTIVE STUDIES; SEX FACTORS; THYROID NEOPLASMS; THYROIDECTOMY;

EID: 0030030103     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19960101)77:1<172::AID-CNCR28>3.0.CO;2-1     Document Type: Article

References (37)

1. Bacourt F, Asselain B, Savoie JC, D'Hubert E, Massin JP, Doucet G, et al. Multifactorial study of prognostic factors in differentiated thyroid carcinoma and a reevaluation of the importance of age. Br J Surg 1986;73:274-7.
2. Carcangiu ML, Zampi G, Pupi A, Castagnoli A, Rosai J. Papillary carcinoma of the thyroid. A clinicopathologic study of 241 cases treated at the University of Florence, Italy. Cancer 1985;55:805-28.
3. Hannequin P, Liehn JC, Delisle MJ. Multifactorial analysis of survival in thyroid cancer. Pitfalls of applying the results of published studies to another population. Cancer 1986;58:1749-55.
4. Kerr DJ, Burt AD, Boyle P, Mac Farlane GJ, Storer AM, Brewin TB. Prognostic factors in thyroid tumors. Br J Cancer 1986;54:475-82.
5. Schelfhout LJ, Creutzberg CL, Hamming JF, Fleuren GJ, Smeenk D, Hermans J. Multivariate analysis of survival in differentiated thyroid cancer: the prognostic significance of the age factor. Eur J Cancer Clin Oncol 1988;324-31.
6. Tennvall J, Bǐsrklund A, M̌sller T, Ranstam J, Akerman M. Is the EORTC prognostic index of thyroid cancer valid in differentiated thyroid carcinoma? Retrospective multivariate analysis of differentiated thyroid carcinoma with long follow-up. Cancer 1986;57:1405-14.
7. Wanebo J, Andrew W, Kaiser D. Thyroid cancer: Some basic considerations. Am J Surg 1981;142:472-9.
8. Chung TC, Sagerman RH, Ryoo MC, King GA, Yu WS, Dalal PS, et al. External irradiation for malignant thyroid cancer. Radiology 1980;136:753-6.
9. Kagan AR, Nussbaum H, Chan P, Levin R. Thyroid carcinoma: is postoperative external irradiation indicated? Oncology 1974;29:40-5.
10. Leisner B, Degelmann G, Dirr W, Kanitz W, Bull U, Langhammer H, et al. Behandlungsergebnisse bei Struma maligna 1960-1980: Stellenwert der perkutanen Nachbestrahlung bei differenzierten Karzinomen. Dtsch Med Wochenschr 1982;107:1702-7.
11. Lenio PT. External irradiation in treatment of papillary carcinoma of the thyroid. Am J Surg 1976;131:281-3.
12. Mazzaferi EL, Young RL. Papillary thyroid carcinoma. A ten year follow-up report on the impact of therapy in 576 patients. Am J Med 1981;70:511-8.
13. Simpson WJ, Panzarrela T, Carruthers JS, Gospodarowicz MK, Sutcliffe SB. Papillary and follicular thyroid cancer: impact of treatment in 1578 patients. Int J Radiat Oncol Biol Phys 1988;14:1063-75.
14. Tubiana M, Haddad E, Schlumberger M, Hill C, Rougier P, Sarrazin D. External radiotherapy in thyroid cancers. Cancer 1985;55:2062-71.
15. Franssila K. Is the differentiation between papillary and follicular thyroid cancer valid? Cancer 1973;32:853-64.
16. Nemec J, Zamrazil V, Pohunkova D, Zeman V, Řshling S. Mode of spread of thyroid cancer. Oncology 1979;36:232-5.
17. Benker G, Olbricht T, Reinwein D, Reiners C, Sauerwein W, Krause, et al. Survival rates in patients with differentiated thyroid carcinoma: influence of postoperative external radiotherapy. Cancer 1990;65:1517-20.
18. SAS Institute, Inc. SAS Technical report P-229, SAS/Stat software, Release 6.07. Cary, NC: SAS Institute, Inc., 1992;435-79.
19. SAS Institute, Inc. SAS/STAT User's Guide, Version 6. 4th ed. Vol. 2. Cary, NC: SAS Institute, Inc., 1989;1027-69.
20. Cady B, Sedgwick CE, Meissner WA, Wool MS, Salzman FA, Werber J. Risk factor analysis in differentiated thyroid cancer. Cancer 1979;143:810-20.
21. Mazzaferi EL. Radioiodine and other treatment and outcomes. Braverman LE, Utiger RD, et al., editors The thyroid. 6th ed. Philadelphia: J.B. Lippincott, 1991;1138-65.
22. Nemec J, Zamrazil V, Pohunkova D, Řshling S. Radioiodine treatment of pulmonary metastases of differentiated thyroid cancer. Results and prognostic factors. Nuklearmedizin 1979;18:86-90.
23. Schlumberger M, Arcangioli O, Piekarski JD, Tubiana M, Parmentier C. Detection and treatment of lung metastases of differentiated thyroid carcinoma in patients with normal chest x-ray. J Nucl Med 1988;29:1790-4.
24. Massin JP, Savoie JC, Garnier H, Guiraudon G, Leger FA, Bacourt F. Pulmonary metastases in differentiated thyroid carcinoma. Study of 58 cases with implications for the primary tumor treatment. Cancer 1984;53:982-92.
25. Nemec J, Pohuncova D, Zamrazil V, Řshling S, Zeman V. Combination of lymph node and lung metastases in thyroid cancer. Neoplasma 1979;26:341-3.
26. Hirabayashi RN, Lindsay S. Carcinoma of the thyroid gland: a statistical study of 390 patients. J Clin Endocrinol Metab 1961;21:1596-610.
27. Harwood J, Clark OH, Dunphy JE. Significance of lymph node metastases in differentiated thyroid cancer. Am J Surg 1978;136:107-12.
28. Williams ED, Path MRC, Doniach I, Path FRC, Bjarnason O, Path FRC, et al. Thyroid cancer in an iodine rich area. A histopathological study. Cancer 1977;39:215-22.
29. Scriba PC, Beckers C, Bürgi A, Escobar Del Rey F, Gembicki M, Koutras DA, et al. Goiter and iodine deficiency in Europe. Report of the subcommittee for the study of endemic goiter and iodine deficiency of the European thyroid association. Lancet 1985;1:1289-93.
30. Hampel R, Kühlberg T, Klein K, Jerichow JU, Pichmann EG, Clausen V, et al. Goiter prevalence in Germany higher than assumed. Med Klin 1995;90:324-9.
31. Hampel R, Kühlberg T, Zöllner H, Klein K, Piechmann EG. Germany - Iodine deficiency area grade I (WHO). Med Klin 1995;90(Suppl II):56.
32. Williamson GS. Anatomy (comparative and embryonal) of special thyroid lymph system, showing its relation to thymus, with some physiological and clinical consideration that follow therefrom. Br J Surg 1930;17:529-50.
33. Reinhoff WF. Lymphatic vessels of thyroid gland in dog and in man. Arch Surg 1931;23:783-804.
34. Russell W, Ibanez ML, Clark RL, White EC. Thyroid carcinoma: classification, intraglandular dissemination, and clinicopathological study based upon whole organ sections of 80 glands. Cancer 1963;16:1425-60.
35. Sautter-Bihl M L, Herbold G, Heinze HG, Bihl H. Postoperative externe Radiotherapie des differenzierten Schilddrüsencarcinoms. Ist eine alleinige Radiojodtherapie ausreichend? Dosimetrische †berlegungen anhand einer Monte-Carlo-Simulation. Strahlenther Oncol 1991;167:267-71.
36. Wheldon TE, O'Donoghue JA, Barrett A, Michalowski AS. The curability of tumors of differing size by targeted radiotherapy using 1-131 or Y-90. Radiother Oncol 1991;21:91-9.
37. Young RL, Mazzaferi EL, Rahe AJ, Dorfman SG. Pure follicular thyroid carcinoma: impact of therapy in 214 patients. J Nucl Med 1980;21:733-7.